Market Cap 3.40M
Revenue (ttm) 61.56M
Net Income (ttm) -31.79M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -51.64%
Debt to Equity Ratio -1.82
Volume 59,900
Avg Vol 1,158,106
Day's Range N/A - N/A
Shares Out 3.59M
Stochastic %K 55%
Beta N/A
Analysts Hold
Price Target $15.00

Company Profile

Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Asia, Africa, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases consisting of syphilis and herpes; SARS-CoV-2; and epstein barr, measles,...

Industry: Medical Devices
Sector: Healthcare
Phone: 353 1 276 9800
Fax: 353 1 276 9888
Address:
IDA Business Park, Bray, Ireland
deepthinker
deepthinker Oct. 25 at 12:44 AM
$TRIB Big news. Perceptive proposes swapping the debt for convertibles, among other things. This means that Perceptive presumably likes the company’s prospects and profitability, including the CGM. Risk of bankruptcy, distressed asset sales, etc. might be alleviated.
1 · Reply
kd1313
kd1313 Oct. 24 at 3:29 PM
$TRIB BS old news. Company dumping shares. Watch out
0 · Reply
Think_Bigly
Think_Bigly Oct. 23 at 7:48 PM
$TRIB - The Company also continues to focus on near term opportunities... with the continued international roll out of its most recently launched products including: its upgraded diabetes care HbA1c testing product, and additional launch countries for its TrinScreen HIV tests. The Company is also continuing to progress towards commercialisation on its pipeline of key medium term strategic growth drivers currently under development, including its innovative: preeclampsia screening test, and prostate cancer test. https://finance.yahoo.com/news/trinity-biotech-reaches-profitability-inflection-130000578.html
0 · Reply
GreedyBastard4Ever
GreedyBastard4Ever Oct. 23 at 6:17 PM
$TRIB time to blow this one up.
0 · Reply
kd1313
kd1313 Oct. 22 at 2:25 PM
$TRIB .89 told you. Shares being dumped on the market. R/S will come
0 · Reply
elmono
elmono Oct. 21 at 2:30 PM
$TRIB cheap as F. Cash flow positive, Nett revs growing…looking forward to earnings
0 · Reply
deepthinker
deepthinker Oct. 20 at 7:34 PM
$TRIB Lifescan emerging from bankruptcy. They still don’t have a CGM after 6 years of trying.
1 · Reply
New072025
New072025 Oct. 18 at 9:54 PM
$TRIB need news
0 · Reply
kd1313
kd1313 Oct. 17 at 3:32 PM
$TRIB slow death, sub dollar now. .50 coming
0 · Reply
elmono
elmono Oct. 16 at 10:42 AM
$TRIB so funny…company is becoming profitable and nett cash flow positive…..severely undervalued and I keep scooping 🤷‍♂️😂…..
1 · Reply
Latest News on TRIB
Trinity Biotech Appoints Paul Tivnan as Non-Executive Director

Aug 21, 2025, 9:00 AM EDT - 2 months ago

Trinity Biotech Appoints Paul Tivnan as Non-Executive Director


Trinity Biotech Plc (TRIB) Q3 2024 Earnings Call Transcript

Nov 15, 2024, 12:37 PM EST - 1 year ago

Trinity Biotech Plc (TRIB) Q3 2024 Earnings Call Transcript


Trinity Biotech Announces Q3 2024 Financial Results

Nov 15, 2024, 9:00 AM EST - 1 year ago

Trinity Biotech Announces Q3 2024 Financial Results


Trinity Biotech to Announce Q3 2024 Financial Results

Nov 14, 2024, 8:07 AM EST - 1 year ago

Trinity Biotech to Announce Q3 2024 Financial Results


Trinity Biotech plc (TRIB) Q2 2024 Earnings Call Transcript

Aug 16, 2024, 3:43 AM EDT - 1 year ago

Trinity Biotech plc (TRIB) Q2 2024 Earnings Call Transcript


Trinity Biotech Announces Q2 2024 Financial Results

Aug 14, 2024, 7:30 AM EDT - 1 year ago

Trinity Biotech Announces Q2 2024 Financial Results


Trinity Biotech to Announce Q2 2024 Financial Results

Aug 13, 2024, 4:05 PM EDT - 1 year ago

Trinity Biotech to Announce Q2 2024 Financial Results


Trinity Biotech Announces Appointment of A New CFO

Jul 9, 2024, 4:05 PM EDT - 1 year ago

Trinity Biotech Announces Appointment of A New CFO


Trinity Biotech plc (TRIB) Q1 2024 Earnings Call Transcript

May 23, 2024, 6:44 PM EDT - 1 year ago

Trinity Biotech plc (TRIB) Q1 2024 Earnings Call Transcript


Trinity Biotech plc to Announce Q1 2024 Financial Results

May 21, 2024, 4:05 PM EDT - 1 year ago

Trinity Biotech plc to Announce Q1 2024 Financial Results


Trinity Biotech plc (TRIB) Q4 2023 Earnings Call Transcript

Apr 4, 2024, 3:03 PM EDT - 1 year ago

Trinity Biotech plc (TRIB) Q4 2023 Earnings Call Transcript


deepthinker
deepthinker Oct. 25 at 12:44 AM
$TRIB Big news. Perceptive proposes swapping the debt for convertibles, among other things. This means that Perceptive presumably likes the company’s prospects and profitability, including the CGM. Risk of bankruptcy, distressed asset sales, etc. might be alleviated.
1 · Reply
kd1313
kd1313 Oct. 24 at 3:29 PM
$TRIB BS old news. Company dumping shares. Watch out
0 · Reply
Think_Bigly
Think_Bigly Oct. 23 at 7:48 PM
$TRIB - The Company also continues to focus on near term opportunities... with the continued international roll out of its most recently launched products including: its upgraded diabetes care HbA1c testing product, and additional launch countries for its TrinScreen HIV tests. The Company is also continuing to progress towards commercialisation on its pipeline of key medium term strategic growth drivers currently under development, including its innovative: preeclampsia screening test, and prostate cancer test. https://finance.yahoo.com/news/trinity-biotech-reaches-profitability-inflection-130000578.html
0 · Reply
GreedyBastard4Ever
GreedyBastard4Ever Oct. 23 at 6:17 PM
$TRIB time to blow this one up.
0 · Reply
kd1313
kd1313 Oct. 22 at 2:25 PM
$TRIB .89 told you. Shares being dumped on the market. R/S will come
0 · Reply
elmono
elmono Oct. 21 at 2:30 PM
$TRIB cheap as F. Cash flow positive, Nett revs growing…looking forward to earnings
0 · Reply
deepthinker
deepthinker Oct. 20 at 7:34 PM
$TRIB Lifescan emerging from bankruptcy. They still don’t have a CGM after 6 years of trying.
1 · Reply
New072025
New072025 Oct. 18 at 9:54 PM
$TRIB need news
0 · Reply
kd1313
kd1313 Oct. 17 at 3:32 PM
$TRIB slow death, sub dollar now. .50 coming
0 · Reply
elmono
elmono Oct. 16 at 10:42 AM
$TRIB so funny…company is becoming profitable and nett cash flow positive…..severely undervalued and I keep scooping 🤷‍♂️😂…..
1 · Reply
Think_Bigly
Think_Bigly Oct. 15 at 10:10 PM
$TRIB LFG..
0 · Reply
MASTER_CHIEF__117
MASTER_CHIEF__117 Oct. 13 at 2:47 PM
$TRIB 1.00 looks like its being accumulated past several weeks. Low floater. No PR in 6 weeks. Chart double bottom. sitrep PT 3.00…awaiting PR update for entry.
0 · Reply
Think_Bigly
Think_Bigly Oct. 12 at 10:41 PM
0 · Reply
deepthinker
deepthinker Oct. 11 at 8:22 PM
$TRIB I think we’re close to something here.
1 · Reply
_CircuitBreaker
_CircuitBreaker Oct. 9 at 11:36 PM
Keep a close watch on CMCT! $TRIB $WINT $ZBIO $PMN _
0 · Reply
kd1313
kd1313 Oct. 8 at 8:35 PM
$TRIB slow death by bad management.
1 · Reply
NeurNet
NeurNet Oct. 7 at 5:32 PM
$TRIB @kd1313 "R/S" : Can we do it... every year ????
1 · Reply
Armyourself
Armyourself Oct. 6 at 3:14 PM
$TRIB Fuck the past tense write up. Where is their 2nd qtr report?
1 · Reply
Think_Bigly
Think_Bigly Oct. 6 at 2:21 AM
$TRIB The WHO Prequalification for TrinScreen HIV serves as a significant barrier to entry for competitors in high-volume screening markets.
0 · Reply
Think_Bigly
Think_Bigly Oct. 6 at 2:16 AM
$TRIB Big Upgrade -In its established HbA1c testing business, Trinity Biotech has also introduced a new column and buffer combination that delivers up to four times the number of injections compared to the existing product. This innovation offers greater stability, requires less calibration, and reduces the cost of goods, enhancing the company's competitiveness and enabling it to target segments of the A1C testing market previously inaccessible due to pricing pressures.
1 · Reply
Think_Bigly
Think_Bigly Oct. 3 at 8:09 PM
$TRIB States clearly: IMMCo a competitive advantage... For whom?
0 · Reply
ajmore
ajmore Oct. 3 at 6:46 PM
$TRIB ready to move! by the look of it.
0 · Reply